Literature DB >> 17521829

Cerebral metabolism and mood in remitted opiate dependence.

Igor I Galynker1, Daniel Eisenberg, John A Matochik, Enid Gertmenian-King, Lisa Cohen, Alane S Kimes, Carlo Contoreggi, Varughese Kurian, Monique Ernst, Richard N Rosenthal, James Prosser, Edythe D London.   

Abstract

BACKGROUND: Opiate-dependent individuals are prone to dysphoria that may contribute to treatment failure. Methadone-maintenance therapy (MMT) may mitigate this vulnerability, but controversy surrounds its long-term use. Little is known about the neurobiology of mood dysregulation in individuals receiving or removed from MMT.
METHODS: Fifteen opiate-abstinent and 12 methadone-maintained, opiate-dependent subjects, who lacked other Axis I pathology, and 13 control subjects were compared on the Cornell Dysthymia Rating Scale (CDRS) and regional cerebral glucose metabolism (rCMRglc) using [(18)F]fluorodeoxyglucose positron emission tomography.
RESULTS: CDRS scores showed no group differences. Opiate-abstinent subjects had lower rCMRglc than control subjects in the bilateral perigenual anterior cingulate cortex (ACC), left mid-cingulate cortex, left insula and right superior frontal cortex. Methadone-maintained subjects exhibited lower rCMRglc than control subjects in the left insula and thalamus. In opiate-abstinent subjects, rCMRglc in the left perigenual ACC and mid-cingulate cortex correlated positively with CDRS scores.
CONCLUSIONS: In remitted heroin dependence, opiate-abstinence is associated with more widespread patterns of abnormal cortical activity than MMT. Aberrant mood processing in the left perigenual ACC and mid-cingulate cortex, seen in opiate-abstinent individuals, is absent in those receiving MMT, suggesting that methadone may improve mood regulation in this population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521829      PMCID: PMC2063442          DOI: 10.1016/j.drugalcdep.2007.03.015

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  39 in total

1.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study.

Authors:  Y I Sheline; D M Barch; J M Donnelly; J M Ollinger; A Z Snyder; M A Mintun
Journal:  Biol Psychiatry       Date:  2001-11-01       Impact factor: 13.382

2.  Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses.

Authors:  Michael Gossop; Duncan Stewart; Nadine Browne; John Marsden
Journal:  Addiction       Date:  2002-10       Impact factor: 6.526

Review 3.  Suicide among heroin users: rates, risk factors and methods.

Authors:  Shane Darke; Joanne Ross
Journal:  Addiction       Date:  2002-11       Impact factor: 6.526

Review 4.  Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression.

Authors:  W C Drevets
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

5.  Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects.

Authors:  M R Daglish; A Weinstein; A L Malizia; S Wilson; J K Melichar; S Britten; C Brewer; A Lingford-Hughes; J S Myles; P Grasby; D J Nutt
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

6.  Neuroimaging studies of mood disorders.

Authors:  W C Drevets
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

7.  Cerebral metabolism in opiate-dependent subjects: effects of methadone maintenance.

Authors:  I I Galynker; S Watras-Ganz; C Miner; R N Rosenthal; D C Des Jarlais; B L Richman; E London
Journal:  Mt Sinai J Med       Date:  2000 Oct-Nov

8.  Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: a whole-hemisphere autoradiography study.

Authors:  Tuija Mantere; Erkki Tupala; Håkan Hall; Terttu Särkioja; Pirkko Räsänen; Kim Bergström; James Callaway; Jari Tiihonen
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

9.  Opioid addiction changes cerebral blood flow symmetry.

Authors:  Lukas Pezawas; Gabriele Fischer; Ivo Podreka; Shird Schindler; Thomas Brücke; Reinhold Jagsch; Maida Thurnher; Siegfried Kasper
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

10.  Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels.

Authors:  Wayne C Drevets; Joseph L Price; Mark E Bardgett; Theodore Reich; Richard D Todd; Marcus E Raichle
Journal:  Pharmacol Biochem Behav       Date:  2002-03       Impact factor: 3.533

View more
  8 in total

Review 1.  Neuroimaging the Effectiveness of Substance Use Disorder Treatments.

Authors:  Elizabeth A Cabrera; Corinde E Wiers; Elsa Lindgren; Gregg Miller; Nora D Volkow; Gene-Jack Wang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-16       Impact factor: 4.147

2.  Predictors of Daily Pain Medication Use in Individuals with Recurrent Back Pain.

Authors:  John A Sturgeon; Jennifer M Hah; Yasamin Sharifzadeh; Stephanie K Middleton; Thomas Rico; Kevin A Johnson; Sean C Mackey
Journal:  Int J Behav Med       Date:  2018-04

3.  Low prefrontal perfusion linked to depression symptoms in methadone-maintained opiate-dependent patients.

Authors:  Jesse J Suh; Daniel D Langleben; Ronald N Ehrman; Jonathan G Hakun; Ze Wang; Yin Li; Samantha I Busch; Charles P O'Brien; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2008-07-31       Impact factor: 4.492

4.  Self-loathing aspects of depression reduce postoperative opioid cessation rate.

Authors:  Jennifer M Hah; Sean Mackey; Peter L Barelka; Charlie K M Wang; Bing M Wang; Matthew J Gillespie; Rebecca McCue; Jarred W Younger; Jodie Trafton; Keith Humphreys; Stuart B Goodman; Fredrick M Dirbas; Peter C Schmidt; Ian R Carroll
Journal:  Pain Med       Date:  2014-06       Impact factor: 3.750

5.  Access to Comprehensive Services for Advanced Liver Disease in the Veterans Health Administration.

Authors:  S Hunter Dunn; Shari S Rogal; Marissa M Maier; Maggie Chartier; Timothy R Morgan; Lauren A Beste
Journal:  Dig Dis Sci       Date:  2019-08-20       Impact factor: 3.199

6.  Neuroimaging reveals distinct brain glucose metabolism patterns associated with morphine consumption in Lewis and Fischer 344 rat strains.

Authors:  Mª Luisa Soto-Montenegro; Verónica García-Vázquez; Nicolás Lamanna-Rama; Gonzalo López-Montoya; Manuel Desco; Emilio Ambrosio
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

7.  Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial.

Authors:  Hubert Mönnikes; Thomas Schwan; Christo van Rensburg; Andrzej Straszak; Carmen Theek; Reinhold Lühmann; Peter Sander; Anne Tholen
Journal:  BMC Gastroenterol       Date:  2013-10-01       Impact factor: 3.067

8.  Factors Associated with Opioid Use in a Cohort of Patients Presenting for Surgery.

Authors:  Jennifer M Hah; Yasamin Sharifzadeh; Bing M Wang; Matthew J Gillespie; Stuart B Goodman; Sean C Mackey; Ian R Carroll
Journal:  Pain Res Treat       Date:  2015-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.